VisionGate, Inc. Alternatives & Competitors
12 companies similar to VisionGate, Inc. — Leading the Battle Against Lung Cancer through our Early Detection Technology
Companies similar to VisionGate, Inc.
LungLife AI
LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analys...
Thousand Oaks, United Sta...
Savicell
THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™
Israel
Exosome Diagnostics, a Bio-Techne brand
ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HG...
Waltham, United States
RhoDx, Inc.
Reducing Cancer Morbidity and Mortality through Early Detection and Monitoring.
United States
Track all VisionGate, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
CellMax Life
Liquid biopsy company focused on cancer screening with a proprietary platform for detectin...
Sunnyvale, United States
Nucleix Ltd.
Developing cancer diagnostic panels based on epigenetic bio markers
Rehovot, Israel
Rarecells
Detect and defeat cancer from its start through a simple blood draw.
Paris, France
Scinvivo B.V.
Optical biopsy for bladder cancer diagnostics
Eindhoven, The Netherland...
Singlera Genomics Incorporated
Detect cancer earlier with the power of circulating tumor methylated DNA (ctmDNA).
La Jolla, United States
Biodesix, Inc.
Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Aw...
Louisville, United States
Cosomil, Inc.
Developing cutting-edge blood-based diagnostics using our groundbreaking Single Enzyme Act...
Japan
About VisionGate, Inc.
VisionGate, Inc. is a pioneering liquid-biopsy technology company focused on combatting lung cancer through early detection technology with a non-intrusive sputum test. Their proprietary Cell-CT™ 3-Dimensional Cell Imaging and Analysis platform forms the basis of their diagnostic capabilities, utilizing optical compute...
Early Detection, Cancer Diagnostics, Liquid Biopsy, Cell-CT Platform, Lung Cancer, Sputum Test, 3D Cell Imaging, Optical Computed Tomography, Biomarkers, Targeted Pharmaceutical Therapies, Non-invasive Testing, Cytopathology Diagnosis
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches VisionGate, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at VisionGate, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
